Constellation Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Constellation Pharmaceuticals (CNST) PT Raised to $55 at Oppenheimer
December 9, 2019 4:21 PM ESTOppenheimer analyst Silvan Tuerkcan raised the price target on Constellation Pharmaceuticals (NASDAQ: CNST) to $55.00 (from $40.00) while maintaining a Outperform rating.
The analyst comments "CNST updated CPI-0610 data with efficacy stable in the key first-line (1L) population (n=15) and excellent tolerability in all settings. SVR35... More
